- Yamamoto Y, Izumikawa K, Hara A, Fujita H, Amenomori M, Sakamoto N, Seki M, Kakeya H, Yanagihara K, Takasaki K, Miyazaki T, Tsuchiya T, Yamasaki N, Tagawa T, Nagayasu T, Kohno S. Importance of controlling drug-resistant Pseudomonas aeruginosa infection: experience from lung transplantation in a cystic fibrosis case. Intern Med. 49: 2353-2358, 2010
- Yamamoto K, Yanagihara K, Sugahara K, Imamura Y, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Hirakata Y, Kamihira S, Kohno S. In vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanisms. Antimicrob Agents Chemother. 53: 3572-3575, 2009
- Yamamoto Y, Shioshita K, Takazono T, Seki M, Izumikawa K, Kakeya H, Yanagihara K, Tashiro T, Otsuka Y, Ohkusu K, Kohno S : An Autopsy case of Erysipelothrix rhusiopathiae endocarditis, Internal Medicine 47: 1437-1440, 2008
- Yanagihara K, Morinaga Y, Nakamura S, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Yamada Y, Kamihira S, Kohno S : Subinhibitory concentrations of telithromycin, clarithromycin and azithromycin reduce methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J antimicrob Chemother 61: 647-650, 2008
- Yamamoto Y, Maesaki S, Kakeya H, Yanagihara K, Ohno H, Ogawa K, Hirakata Y, Tomono K, Koga H, Tashiro T, Kohno S: Combination therapy with Fluconazole and Flucytosine for pulmonary Cryptococcosis. Chemotherapy 43: 436-441, 1997
- Yamamoto Y, Kohno S, Koga H, Kakeya H, Tomono K, Kaku M, Yamazaki T, Arisawa M, Hara K : Random Amplified Polymorphic DNA Analysis of Clinically and Environmentally Isolated Cryptococcus neoformans in Nagasaki. J. Clin. Microbiol. 33: 3328-3332, 1995
|
|